Vincent van Houten, MSc
Vincent van Houten joined Forbion in 2007 and as of January 2016 is Chief Financial Officer of Forbion.
Since his employment at Forbion he has played an active role in setting up and maintaining the Forbion investment funds. Vincent holds a Master’s degree from the University of Amsterdam and has a Finance and Accounting background. He is responsible for the overall financial and fiscal matters of the Forbion group. Vincent has experience in corporate and fiscal (re)structuring. In that respect he also assists the Investment Team on portfolio related financial topics. In addition Vincent since 2012 was partially seconded by Forbion to act as Chief Financial Officer of Dezima Pharma B.V. ( a Forbion portfolio company). As such he has also played an active role in the sale of Dezima to Amgen in 2015.